COP vs PG: Which Is the Better Buy?

Side-by-side comparison of ConocoPhillips and The Procter & Gamble Company β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
ConocoPhillips Β· Energy
$107.74
-21.3% upside to fair value
Grade D High Quality
VS
The Procter & Gamble Company Β· Consumer Defensive
$150.38
+10.0% upside to fair value
Grade B High Quality
QuantHub Verdict
PG has more upside to fair value (+10.0%). COP trades at a lower forward P/E (18.3x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric COP PG
Current Price $107.74 $150.38
Fair Value Estimate $84.75 $165.39
Upside to Fair Value -21.3% +10.0%
Market Cap $131.3B $350.2B
Forward P/E 18.3x 21.5x
EV / EBITDA 6.1x 15.1x
Price / Sales 2.2x 4.0x
Price / FCF 8.5x 23.3x
Revenue Growth YoY -2.5% +7.4%
Gross Margin 29.2% 50.3%
Operating Margin 18.3% 23.2%
Return on Equity 11.3% 31.3%
Dividend Yield 0% 0%
FCF Yield 11.72% 4.29%
Analyst Consensus Strong Buy Buy
Investment Thesis
COP β€” ConocoPhillips
ConocoPhillips is a leading global oil and gas exploration and production company with a strong competitive position as the largest producer in Alaska and a top-five international producer following recent acquisitions. The company benefits from a durable moat supported by scale advantages, a broad international footprint, and a shareholder-focused capital allocation strategy under CEO Ryan Lance…
PG β€” The Procter & Gamble Company
The Procter & Gamble Company is a leading global consumer defensive company specializing in household and personal products with a strong portfolio across fabric care, baby and family care, beauty, health care, and grooming. The business quality is high, supported by a durable competitive moat from strong brands, consistent earnings growth, and prudent capital allocation emphasizing dividends and…
Accumulation Zones
Metric COP PG
Zone Low $63.56 $124.04
Zone High $72.04 $140.58
In Buy Zone? No No
← COP Research    PG Research β†’    All Research